You just read:

Entest BioMedical's Chairman Discusses its Subsidiary, Zander Therapeutics, Inc.'s Progress With Small Molecule Immunotherapies for Treating Cancer and Arthritis in Dogs

News provided by

Entest BioMedical Inc.

Apr 26, 2017, 08:30 ET